Related references
Note: Only part of the references are listed.Serine 220 phosphorylation of the Merkel cell polyomavirus large T antigen crucially supports growth of Merkel cell carcinoma cells
David Schrama et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects
Pini Matzner et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Merkel cell carcinoma: An algorithm for multidisciplinary management and decision-making
Isabel Prieto et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Tumorigenic Activity of Merkel Cell Polyomavirus T Antigens Expressed in the Stratified Epithelium of Mice
Megan E. Spurgeon et al.
CANCER RESEARCH (2015)
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma
Paul William Harms et al.
CANCER RESEARCH (2015)
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas
Stephen Q. Wong et al.
CANCER RESEARCH (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Amita Patnaik et al.
CLINICAL CANCER RESEARCH (2015)
Intratumoral delivery of Interleukin-12 DNA via in vivo electroporation leads to regression of injected and non-injected tumors in Merkel cell carcinoma: Final Results of a phase 2 study
S. Bhatia et al.
EUROPEAN JOURNAL OF CANCER (2015)
How Does the Merkel Polyomavirus Lead to a Lethal Cancer? Many Answers, Many Questions, and a New Mouse Model
Candice D. Church et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Merkel Cell Polyomavirus Small T Antigen Is Oncogenic in Transgenic Mice
Monique E. Verhaegen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control
Laura Pacini et al.
JOURNAL OF VIROLOGY (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
The Role of Merkel Cell Polyomavirus and Other Human Polyomaviruses in Emerging Hallmarks of Cancer
Ugo Moens et al.
VIRUSES-BASEL (2015)
Targeting the tumor microenvironment to enhance antitumor immune responses
Kevin Van der Jeught et al.
Oncotarget (2015)
Large T and small T antigens of Merkel cell polyomavirus
Justin A. Wendzicki et al.
CURRENT OPINION IN VIROLOGY (2015)
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
Benjamin Boyerinas et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma
Jayasri G. Iyer et al.
CANCER MEDICINE (2015)
Nivolumab in melanoma: latest evidence and clinical potential
Douglas B. Johnson et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
Nivolumab in NSCLC: latest evidence and clinical potential
Raghav Sundar et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
Paolo A. Ascierto et al.
EBIOMEDICINE (2015)
Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse Model
Masahiro Shuda et al.
PLOS ONE (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Spontaneous regression of Merkel cell carcinoma: A case report and review of the literature
C. Pang et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2015)
CD8+ Lymphocyte Intratumoral Infiltration as a Stage-Independent Predictor of Merkel Cell Carcinoma Survival A Population-Based Study
Kelly G. Paulson et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors
Rikke Lyngaa et al.
CLINICAL CANCER RESEARCH (2014)
CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
Lidia Robert et al.
CLINICAL CANCER RESEARCH (2014)
Programmed death-1 pathway in cancer and autoimmunity
Ariel Pedoeem et al.
CLINICAL IMMUNOLOGY (2014)
Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma
Auris O. Huen et al.
CURRENT OPINION IN ONCOLOGY (2014)
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Requires Viral Small T-Antigen for Cell Proliferation
Masahiro Shuda et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I
Aude G. Chapuis et al.
CANCER IMMUNOLOGY RESEARCH (2014)
CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
Hye-Jung Kim et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
Chad Tang et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Downregulation of MHC-I Expression Is Prevalent but Reversible in Merkel Cell Carcinoma
Kelly G. Paulson et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Merkel Cell Carcinoma: 30-Year Experience from a Single Institution
Juan A. Santamaria-Barria et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Merkel Cell Polyomavirus Small T Antigen Controls Viral Replication and Oncoprotein Expression by Targeting the Cellular Ubiquitin Ligase SCFFbw7
Hyun Jin Kwun et al.
CELL HOST & MICROBE (2013)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Suppression, subversion and escape: the role of regulatory T cells in cancer progression
K. Oleinika et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers
Olga K. Afanasiev et al.
CLINICAL CANCER RESEARCH (2013)
Systemic Immune Suppression Predicts Diminished Merkel Cell Carcinoma-Specific Survival Independent of Stage
Kelly G. Paulson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Vascular E-Selectin Expression Correlates with CD8 Lymphocyte Infiltration and Improved Outcome in Merkel Cell Carcinoma
Olga K. Afanasiev et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Tumor-Specific T Cells in Human Merkel Cell Carcinomas: A Possible Role for Tregs and T-Cell Exhaustion in Reducing T-Cell Responses
Mitra Dowlatshahi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
At the Bedside: CTLA-4-and PD-1-blocking antibodies in cancer immunotherapy
Margaret K. Callahan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
The T Antigen Locus of Merkel Cell Polyomavirus Downregulates Human Toll-Like Receptor 9 Expression
Naveed Shahzad et al.
JOURNAL OF VIROLOGY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages
Mario Henrique M. Barros et al.
PLOS ONE (2013)
Merkel cell polyomavirus: A newly discovered human virus with oncogenic potential
Megan E. Spurgeon et al.
VIROLOGY (2013)
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Evan J. Lipson et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity
Timothy S. Fisher et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Type I and II IFNs Inhibit Merkel Cell Carcinoma via Modulation of the Merkel Cell Polyomavirus T Antigens
Christoph Willmes et al.
CANCER RESEARCH (2012)
Tumor Infiltrating Immune Cells and Outcome of Merkel Cell Carcinoma: A Population-Based Study
Harri Sihto et al.
CLINICAL CANCER RESEARCH (2012)
An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells
Roland Houben et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Chronic Lymphocytic Leukemia Is Associated With Decreased Survival of Patients With Malignant Melanoma and Merkel Cell Carcinoma in a SEER Population-Based Study
Jerry D. Brewer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Nitric Oxide-Producing Myeloid-Derived Suppressor Cells Inhibit Vascular E-Selectin Expression in Human Squamous Cell Carcinomas
Ahmed E. Gehad et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Merkel cell carcinoma: The prognostic implications of an occult primary in stage IIIB (nodal) disease
Matthew Foote et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype
Aude G. Chapuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Differentiation and gene expression profile of tumor-associated macrophages
Astrid Schmieder et al.
SEMINARS IN CANCER BIOLOGY (2012)
Development of a DNA vaccine targeting Merkel cell polyomavirus
Qi Zeng et al.
VACCINE (2012)
Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma
C. Martel-Jantin et al.
VIROLOGY (2012)
Plasmid IL-12 electroporation in melanoma
Edward Cha et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties
T. Tadmor et al.
ANNALS OF ONCOLOGY (2011)
Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood
Jayasri G. Iyer et al.
CLINICAL CANCER RESEARCH (2011)
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator
Masahiro Shuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
Kelly G. Paulson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Serological evidence of Merkel cell polyomavirus primary infections in childhood
Tingting Chen et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Merkel Cell Polyomavirus Status Is Not Associated with Clinical Course of Merkel Cell Carcinoma
David Schrama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas
Sofia Asioli et al.
MODERN PATHOLOGY (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Antibodies to Merkel Cell Polyomavirus T Antigen Oncoproteins Reflect Tumor Burden in Merkel Cell Carcinoma Patients
Kelly G. Paulson et al.
CANCER RESEARCH (2010)
Merkel Cell Polyomavirus and Two Previously Unknown Polyomaviruses Are Chronically Shed from Human Skin
Rachel M. Schowalter et al.
CELL HOST & MICROBE (2010)
The new polyomavirus (MCPyV) does not affect the clinical course in MCCs
J. Handschel et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2010)
Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study
Jorge Albores-Saavedra et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2010)
Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens
Roland Houben et al.
JOURNAL OF VIROLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Nuclear localization of Merkel cell polyomavirus large T antigen in Merkel cell carcinoma
Tomoyuki Nakamura et al.
VIROLOGY (2010)
Merkel Cell Polyomavirus in Cutaneous Swabs
Vincent Foulongne et al.
EMERGING INFECTIOUS DISEASES (2010)
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
Youjin Lee et al.
BLOOD (2009)
Screening of the specific polyoma virus as diagnostic and prognostic tools for Merkel cell carcinoma
Hideki Nakajima et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2009)
Clinical Factors Associated With Merkel Cell Polyomavirus Infection in Merkel Cell Carcinoma
Harri Sihto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Association of Merkel Cell Polyomavirus-Specific Antibodies With Merkel Cell Carcinoma
Joseph J. Carter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus
Diana V. Pastrana et al.
PLOS PATHOGENS (2009)
Merkel Cell Carcinoma Histologic Features and Prognosis
Aleodor A. Andea et al.
CANCER (2008)
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients:: the AEIOU features
Michelle Heath et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Expression of VEGF-A/C, VEGF-R2, PDGF-α/β, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma
Markus Brunner et al.
MODERN PATHOLOGY (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus
Masahiro Shuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Clonal integration of a polyomavirus in human Merkel cell carcinoma
Huichen Feng et al.
SCIENCE (2008)
Revival of CD8+ Treg-mediated suppression
Trevor R. F. Smith et al.
TRENDS IN IMMUNOLOGY (2008)
Investigation of mechanisms underlying the T-cell response to the hapten 2,4-dinitrochlorobenzene
Chris Pickard et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Partial regression of merkel cell carcinoma in response to withdrawal of azathioprine in an immunosuppression-induced case of metastatic merkel cell carcinoma
R. Muirhead et al.
CLINICAL ONCOLOGY (2007)
Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C
Simon S. Brack et al.
CLINICAL CANCER RESEARCH (2006)
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
RH Thompson et al.
CANCER RESEARCH (2006)
Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance
Changping Wu et al.
ACTA HISTOCHEMICA (2006)
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
Y Ohigashi et al.
CLINICAL CANCER RESEARCH (2005)
Merkel cell carcinoma: Prognosis and treatment of patients from a single institution
PJ Allen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Merkel cell carcinoma: Changing incidence trends
NC Hodgson
JOURNAL OF SURGICAL ONCOLOGY (2005)
Immune surveillance in the skin: Mechanisms and clinical consequences
TS Kupper et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Complete remission of Merkel cell carcinoma of the scalp with local and regional metastases after topical treatment with dinitrochlorbenzol
G Herrmann et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Epidemiology of primary Merkel cell carcinoma in the United States
M Agelli et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Immunosuppression and Merkel cell cancer
JF Buell et al.
TRANSPLANTATION PROCEEDINGS (2002)
Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine
MM Friedlaender et al.
TRANSPLANTATION (2002)
Merkel cell carcinoma and HIV infection
EA Engels et al.
LANCET (2002)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
